Skip to main content
. Author manuscript; available in PMC: 2020 Jun 1.
Published in final edited form as: J Vasc Surg. 2019 Feb 15;69(6):1924–1935. doi: 10.1016/j.jvs.2018.08.172

Figure 6. SG-1002 therapy preserves capillary density in ischemic hindlimbs.

Figure 6.

Representative micrographs shown of CD31 immunostained muscle tissue obtained from placebo nonischemic (Figure 6A), ischemic (Figure 6B) and SG-1002 nonischemic (Figure 6C), ischemic (Figure 6D) hindlimbs at day 42 post-ALI. Arrows denote CD31 -positive staining of capillaries and capillary density quantified (Figure 6E). Values are means ± SEM with number of animals per group shown. NS, not significant.